当前位置：首页 > 文献互助 > 互助详情

Three-dimensional Biopharmaceutics and Clinical Considerations of Drugs for Safety and Efficacy: A Review Study复制

用户48_KcjR1ENS0 1天前 11 10 待确认 帖子自动结束时间: 2025-06-09 15:17:28

1. 请及时下载文件确认是否正确, 系统将在 2025-06-11 15:17:49 删除文件

2. 如若文件有误请驳回应助文件, 求助状态即回到求助中

3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.32598/pbr.11.1.1203.1复制

文献链接: https://pbr.mazums.ac.ir/article-1-571-en.html复制

其他信息:

出版社: Negah Scientific Publisher
作者: Sunday O. Awofisayo; Akwaowoh E. Akpabio; Emmanuel O. Olorunsola; Matthew I. Arhewoh
全文下载地址: https://pbr.mazums.ac.ir/article-1-571-en.pdf

上一篇：Pediatric keratoconus

下一篇：Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: A randomized, double-blind, placebo-controlled phase 3 trial

互助时间线

2025-06-04 15:17:49 [上传文件]

数据追踪者上传了文件(pdf 964.15 KB), 求助状态变成 待确认

2025-06-04 15:17:28 [发起求助]

最新发布的求助

The enduring metabolic improvement of combining dual amylin and calcitonin receptor agonist and semaglutide treatments in a rat model of obesity and diabetes 38分钟前
分光光度法测定发芽和未发芽的蚕豆 （Vicia faba L.） 和鹰嘴豆 （Cicer aritinum L.） 中的 L-多巴 1小时前
Cardiovascular toxicities of hypoxia-inducible factor prolyl hydroxylase inhibitors: a disproportionality analysis based on JADER database 1小时前
Efficacy and Safety of Shou Hui Tong Bian Capsules in the Treatment of Functional Constipation in Middle-Aged and Elderly Patients: A Multicenter, Randomized, Controlled Trial 2小时前
FMO2 ameliorates nonalcoholic fatty liver disease by suppressing ER-to-Golgi transport of SREBP1 13小时前
A first-in-human phase 1/2 dose-escalation study of MAK683 (EED inhibitor) in patients with advanced malignancies 19小时前
Catalytic Hydrogenation of Nitriles over Supported Mono- and Bimetallic Catalysts 21小时前
Unique Binding Sites of Uricosuric Agent Dotinurad for Selective Inhibition of Renal Uric Acid Reabsorptive Transporter URAT1 21小时前
Oral iptacopan monotherapy in paroxysmal nocturnal haemoglobinuria: final 48-week results from the open-label, randomised, phase 3 APPLY-PNH trial in anti-C5 … 21小时前
A first-in-human phase 1/2 dose-escalation study of MAK683 (EED inhibitor) in patients with advanced malignancies 23小时前
Nutrition support whilst on glucagon-like peptide-1 based therapy. Is it necessary? 1天前
Efficacy, Safety, and Tolerability of Oral DFD-29, a Low-Dose Formulation of Minocycline, in Rosacea 1天前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com